Primary pulmonary hypertension is a rare disease of unknown cause. Functional hyposplenism is characterized by the appearance ofabnormal circulating erythrocytes despite the presence of a spleen and is associated with a variety of disease states. A case of primary pulmonary hypertension associated with functional hyposplenism is described in this report.
Introduction
Primary pulmonary hypertension is a rare disease of unknown aetiology usually affecting young adult females. It is characterized by progressive right heart failure typically causing death within 3 years of diagnosis.' Pathologically it is recognized by changes in muscular pulmonary arteries consisting of medial hypertrophy intimal proliferation and plexiform lesions. 2 Functional hyposplenism is an uncommon condition characterized by the appearance of abnormal erythrocytes (Howell-Jolly bodies, target cells, acanthocytes, siderocytes) and platelets in the blood despite the presence of a spleen. It is associated with sickle cell disease, coeliac disease, inflammatory bowel disease, amyloidosis and splenic artery thrombosis.'
We now report a patient with primary pulmonary hypertension and functional hyposplenism. Possible explanations for this previously undescribed association are discussed.
Case report
A 39 year old female presented with a 3 week history of progressive dyspnoea and chest pain. The history was otherwise unremarkable. Physical examination revealed features ofright heart failure. The chest X-ray demonstrated an enlarged main pulmonary artery. Isotope lung scanning revealed multiple mismatches of ventilation and perfusion. The full blood count was normal apart from a mean corpuscular volume (MCV) of 101 fl. A blood film was not examined at this time. Doppler studies of the veins of the lower limbs were unremarkable. A diagnosis of right heart failure secondary to multiple pulmonary emboli of unknown origin was made and she was treated with anticoagulants and diuretics.
Two years later she presented with symptoms and signs of worsening right heart failure. Cardiac catheterization, after treatment ofthe heart failure, revealed the following resting pressures: right atrium (mean) 10 mmHg, right ventricle 38/11 mmHg, pulmonary artery 39/25 (mean 31 mmHg), pulmonary artery wedge 7 mmHg. Cardiac output was 2.55 1/min. Further isotope lung scanning revealed persistent mismatches of ventilation and perfusion. Bilateral lower limb venography was normal. Ultrasound examination of the abdomen revealed hepatomegaly with dilated hepatic veins consistent with congestive failure but the spleen was of normal size. Incidental findings included the presence of gallstones and a uterine fibroid. Blood film demonstrated Howell-Jolly bodies, anisocytes, spherocytes, macrocytes and macrothrombocytes. The haemoglobin measured 19.6 g/dl. The total red cell count was 5.91 x 1012/1 which was above the normal range of 3.8-5.8 x 1012/1. The haematocrit was 62.8% (normal range 37-47%). Platelet count was normal as was the activated partial thromboplastin time (APTT). Antithrombin III levels were within the normal range. Protein S and C estimations were not performed.
Arterial blood gas analysis showed a P02 of 9.57 kPa and the Pco2 was 3.79 kPa. Serum erythropoietin was 50 mU/ml (normal = 5 -30 mU/l). MCV was 106 fl. Serum vitamin B12, folic acid and thyroid function were all normal. Serum liver function tests were abnormal: total bilirubin elevated to 24 jtmol/l (normal range 0-17 ytmol), aspartate transaminase 42 IU/l (range 7-40 IU/1). These were compatible with liver congestion and fluctuated during the clinical course in relation to the severity of heart failure. Antinuclear antibody was positive at a titre of 1/160 but tests for antibodies to double-stranded DNA, extractable nuclear antigen, smooth muscle, mitochondria and reticulin were negative. Rheumatoid factor was absent. Serum was not examined for the presence of antiphospholipid antibodies.
Over the next 4 years right heart failure gradually worsened. She was finally admitted suffering from atrial fibrillation and hypotension, developed pulmonary oedema and died.
At autopsy, the heart showed marked right ventricular hypertrophy (weight 120 g). There was evidence of previous ischaemia (widespread.foci of fibrosis) with recent infarction involving the anterior papillary muscle of the right ventricle. There was also extensive interstitial fibrosis of the left ventricle. The coronary arteries were normal.
Histological examination of the lungs revealed fibrous proliferation of the intima of small arteries and arterial dilation lesions including angiomatoid and plexiform lesions. There were also many organized and recanalized thrombi.
Grossly, the spleen was markedly atrophic weighing 4 g. Histological examination showed sinusoidal atrophy with collapse ofthe capsule and trabeculae. Parenchymal vessels showed intimal proliferation. One of the smaller splenic arteries showed a recanalized thrombous. Gamna-Gandi bodies were also evident. These features suggested acquired splenic atrophy. The small intestinal mucosa was normal. The liver showed severe centrilobular venous congestion progressing to fibrosis.
Discussion
Primary pulmonary hypertension is a rare disease characterized by unexplained elevation of pulmonary blood pressure. It is typified by a relatively brief clinical course which usually terminates in right heart failure within a short time following diagnosis. Hyposplenism is an uncommon condition most often related to splenectomy. Occasionally hyposplenic changes are noted in the peripheral blood when the spleen is present; this is then termed functional hyposplenism.
This patient had pulmonary hypertension, the cause of which was uncertain during life. Although the presence of mismatched ventilation and perfusion suggested thromboembolic disease, postmortem examination revealed the diagnosis of primary pulmonary hypertension.4 In addition, thrombosis in situ was noted in the pulmonary blood vessels. This would have explained the abnormal ventilation perfusion scans5 seen during the earlier part of the clinical course.
Serial ultrasound examinations had consistently documented normal splenic size from the time of presentation until 8 months before death. By the time of autopsy, however, the spleen had shrunk to weigh only 4 g. Despite the normal splenic size, function was impaired as reflected by the appearance of abnormal erythrocytes and platelets in the blood.
It is unclear in this case whether the development of primary pulmonary hypertension caused functional hyposplenism or if some other disease caused both pulmonary hypertension and functional hyposplenism. The first possibility could be explained by the complications of primary pulmonary hypertension which could be expected to cause splenic ischaemia, hypofunction and eventually atrophy: namely, reduced cardiac output, splenic venous hypertension, hypoxia and polycythaemia.6 These factors would also predispose to splenic arterial thrombosis which would further compromise splenic perfusion and function.3 However, if these were the only causes of functional hyposplenism in this patient, one would expect previous reports of functional hyposplenism in patients with primary pulmonary hypertension and other causes of cor pulmonale.
An alternative is that another disease caused both pulmonary hypertension and functional hyposplenism. The only diseases known to cause both are systemic lupus erythematosus7'8 and rheumatoid arthritis.9"0 While this patient had a positive antinuclear antibody titre of 1/160 this is not uncommon in primary pulmonary hypertension" and there were no other immunological or clinical features of these diseases.
An underlying thrombotic diathesis is suggested by the presence of splenic arterial thrombosis, myocardial infarction with normal epicardial coronary arteries, and possibly by multiple pulmonary arterial thromboses. Antithrombin 3 levels were normal but protein S and C estimations were not performed. Antiphospholipid antibodies have been associated with pulmonary hypertension'2 and splenic infarction'3 but not functional hyposplenism. Unfortunately serum was not tested for the presence of antiphospholipid antibodies in this patient. This patient, however, had no history of recurrent spontaneous abortions and had a consistently normal APTT and platelet count making the diagnosis of the primary antiphospholipid syndrome unlikely. 
